Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-28T01:06:08.774Z Has data issue: false hasContentIssue false

Clinical factors affecting functioning in patients with schizophrenia or schizoaffective disorder

Published online by Cambridge University Press:  01 September 2022

C. Neily*
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
N. Charfi
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
G. Smaoui
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
N. Feki
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
R. Omri
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
L. Zouari
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
J. Ben Thabet
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
M. Maâlejboauli
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
M. Maalej
Affiliation:
Hedi Chaker hospital, Psychiatry Department, Sfax, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Schizophrenia is often associated with impaired functioning abilities due to its disabling symptoms.

Objectives

to determine the clinical factors that impact the functioning in stabilized patients withschizophrenia and schizoaffective disorder.

Methods

We conducted a cross-sectional, descriptive and analytical study. It was carried out on an outpatient population with schizophrenia or schizoaffective disorder diagnosis. We used the Functional Assessment Staging Scale (FAST) to measure the functional capacity, the PANSS to assess psychosis symptom severity and the Calgary scale to screen for comorbid depression.

Results

Seventy-five patients were included with 61 males (81.3%).The mean age was 39.81 ± 9.96 years. The mean sore of the Fast scale was 33 ± 14.95. 90% of our patients scored higher than 11 on the FAST scale revealing a functioning deficiency. 18.7% scored higher than 6 on the Calgary scale revealing a comorbid depression .No significant correlations were found between the FAST score and the age of patient, the gender,the age of onset of psychosis, the duration of untreated psychosis and the number of life-time episodes. Scores of PANSS were significantly higher among patients with a functioning deficiency (p<0.00).No significant correlation was found between the FAST score and the Calgary score.

Conclusions

Our study suggests that the severity of residual positive and negative symptoms affects negatively the functioning of patients with schizophrenia or schizoaffective disorder. Thus, targeting those symptoms in the treatment may have significant functional benefits.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.